Net loss of Mangalam Drugs and Organics reported to Rs 13.80 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore during the previous quarter ended June 2024. Sales declined 25.21% to Rs 57.21 crore in the quarter ended June 2025 as against Rs 76.49 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 57.21 | 76.49 | -25 |
| OPM % | -7.83 | 10.71 | - |
| PBDT | -8.52 | 4.46 | PL |
| PBT | -13.00 | 0.58 | PL |
| NP | -13.80 | 2.68 | PL |